Lifetime Medical Expenditures Associated with ith Physical Ph i l Activity A ti it and dO Overweight i ht – A Simulation Approach Jeroen van Meijgaard – UCLA School of Public Health Academy Health June 2010 BACKGROUND Physical Activity and Obesity are predictors for morbidity, mortality t lit and d medical di l expenditures dit Physical Activity and Obesity change over individual life titimes Planning is difficult because no good long term follow up data evaluating expenditure conditional on early life physical activity and obesity Simulation can be used: stochastic process for physical activity and obesity combined w/ data on short term response p conditional on p physical y activity y and obesity y of expenditures BACKGROUND - continued Some analyses that estimate lifetime expenditures conditional on obesity (but not physical activity) in early life and mid-life: mid life: • Daviglus et al (2004): Observed data (Medicare linked with Chicago Heart Study data) – Steep increase in lifetime expenditures w/ obesity – No data on survival • Finkelstein et al (2008): Estimated expenditures taking into account survival – Small increase in expenditures w/ obesity – increase is p partially y mitigated g by y lower survival • van Baal et al (2008): Markov model based on Netherlands data using chronic disease states – Decrease in expenditures w/ obesity due to substantially lower survival DATA – UNITED STATES, 2004 Parameter estimates and population level summary data to calibrate the model, model chosen to represent US population (2004): 1 Population by gender and age (NCHS - 2004) 1. 2. Physical Activity distribution by gender and age (NHIS – 2002-2006) 3 Body Mass Index distribution by gender and age (NHIS – 2002 3. 2002-2006) 2006) 4. Medical expenditures conditional on physical activity and body mass index, by gender and age (Linked NHIS-MEPS – 2002-2006) 5. Mortality risks by gender and age (NCHS Vital Statistics – 2003-2005) 6. Relative risks of physical activity and body mass index on mortality (NHIS-HPDP, 1990-1991, linked with mortality data, augmented with estimates from the literature) METHODS – SIMULATION AND SENSITIVITY ANALYSIS Data and processes are integrated into a microsimulation framework, simulating life course of individuals from birth till death Simulate processes of physical activity and body mass index over the life course by age and gender Mortality and expenditures are conditional on physical activity and body mass index by age and gender Uncertainty U t i t in i iinputt parameters t is i iincorporated t d th through h standard errors from estimates Simulated runs are repeated 1 1,000 000 times times, each time for a different parameter vector, randomly drawn from a hypercube METHODS – LIFE COURSE DATA PROCESSES Leisure Time Physical Activity is based on self reported frequency and duration of moderate and vigorous exercise, translated to METhrs/wk. Based on longitudinal data process is modeled with two parts: annual variation + individual component that follows autoregressive process: it it 1 it , ln( PAit ) s( PA ) Agei it it , Body Mass Index is based on self reported weight and heights. It is modeled as an autoregressive process, where deviation of the population mean in BMI is based in the deviation from the population mean in the previous year plus a small innovation it it 1 it , 1 LBMI it x( LBMI ) Ageit , ln( PAit ) it BMI it METHODS – PARAMETERIZATION OF RR(PA) 1 Releattive Risk (RR R) 0.8 RR 1 1 0.0245 PA 0.6 04 0.4 0.2 0 0 8 16 24 32 40 48 Ph i l Activity Physical A ti it (PA in i METhrs/w METh / eek) k) 56 64 METHODS – PARAMETERIZATION OF RR(BMI) Parameterized Relative Risk of BMI on Mortality (Male by Age) 3.5 Relative Risk of Mortality 3 2.5 25 2 40 55 1.5 70 1 0.5 0 18 20 22 24 26 28 30 32 34 36 38 40 BMI Parameterized Relative Risk of BMI on Mortality (Female by Age) 3.5 Relative Risk of Mortality 3 2.5 25 2 40 55 1.5 70 1 05 0.5 0 18 20 22 24 26 28 30 BMI 32 34 36 38 40 METHODS – IMPACT OF PA AND BMI ON EXPENDITURES Medical expenditures were estimated using linked NHISMEPS data from 2002-2006 using a GLM framework. Subsequently expenditures were simulated conditional Subsequently, on PA and BMI stratified by gender (s) and age (a): E ( MedExp) g ( s, a, PA, BMI ) sa exp i( sa ) Di i RESULTS – TOTAL MEDICAL EXPENDIUTRES CONDITIONAL ON PA AND BMI AT AGE 25 C di i l on Status Conditional S at Age=25 A 25 M l Male F Female l LE Avg Annual Exp. Cumulative Exp. LE Avg Annual Exp. Cumulative Exp. 52.4 (ref) 4,862 (ref) 254,710 (ref) 57.0 (ref) 5,839 (ref) 332,784 (ref) Overweight (25-29.9 kg/m2) -0.1 (0.28) +182 (0.04) +9,206 (0.05) -0.0 (0.32) +179 (0.02) +9,981 (0.02) Class I Obesity (30-34.9 kg/m2) -0.7 (<0.01) +449 (<0.01) +20,012 (0.01) -0.3 (0.03) +419 (<0.01) +22,221 (<0.01) Class II/III Obesity (>35 kg/m2) -1.7 (<0.01) +571 (<0.01) +20,939 (0.03) -0.8 (<0.01) +705 (<0.01) +35,202 (<0.01) 51.6 ( f) (ref) 5,040 ( f) (ref) 260,228 ( f) (ref) 56.5 ( f) (ref) 6,039 ( f) (ref) 341,201 ( f) (ref) Somewhat Active (8-16 METhrs/wk) +0.5 (<0.01) -4 (0.40) +2,191 (0.03) +0.4 (<0.01) -31 (0.23) +324 (0.37) Very Active (≥16 METhrs/wk) +1.0 (<0.01) -14 (0.34) +4,091 (0.05) +0.7 (<0.01) -63 (0.21) -106 (0.48) BMI category Normal weight (18.5-24.9 kg/m2) reference Physical Activity category Sedentary y ((0-8 METhrs/wk)) – reference RESULTS – ANNUAL EXPENDITURES BY AGE CONDITIONAL ON BMI STATUS AT AGE 25 Average annual cost conditional on BMI at age 25, males Average annual cost conditional on BMI at age 25, females $10,212 $10,040 85+ $10,031 $10,058 $9,857 85+ $9,865 $10,612 $10,233 $9,893 $9,518 65 84 65-84 $9,150 $9,827 , $9,382 65 84 65-84 $9,083 $9,252 $9,017 $5 663 $5,663 45-64 $5,659 $4,698 $5,357 $2,103 25-44 $3,905 $2,064 $3,650 25-44 $1,845 $1 648 $1,648 $0 18.5 - 24.9 $5,906 45-64 $5,139 $3,404 $3 175 $3,175 $5,000 $10,000 $0 $5,000 30.0 - 34.9 25.0 - 29.9 $6 172 $6,172 $5,496 35.0 + $10,000 DISCUSSION Results similar to previous studies where physical activityy was not incorporated: p impact p of BMI on lifetime medical expenditures smaller than in observational study (Daviglus et al, 2004); but positive where it is negative on similar simulation study (van Baal et al, 2008). Differences in lifetime medical expenditures also driven b change by h iin lif life expectancy t Benefit of improvements in life expectancy may be valued to compare total benefits Lack of data make it difficult to validate the model Assumed that long term impact of behavior is mediated through behavior; however chronic disease states may play important role